Starting a GLP-1 medication isn’t like flipping a switch. These drugs are introduced gradually, in a process called dose escalation, for good reason. Understanding what’s happening and why can make those first few weeks a lot easier to navigate.
Why Doses Start Low
GLP-1 medications can cause nausea, vomiting, and other GI side effects, especially in the beginning. Starting at a low dose and gradually increasing it over several weeks or months allows your body to adjust, minimizes side effects, and helps you find the dose that works best for you without unnecessary discomfort. Think of it like slowly turning up the volume rather than blasting it from the start.
A Typical Escalation Schedule
While schedules vary by medication and prescriber, here’s a general sense of how Wegovy® dose escalation works:
Weeks 1–4: 0.25 mg per week (starting dose below therapeutic level, purely for tolerance)
Weeks 5–8: 0.5 mg per week
Weeks 9–12: 1.0 mg per week
Weeks 13–16: 1.7 mg per week
Week 17 onward: 2.4 mg per week (maintenance dose)
For tirzepatide (Zepbound®), the escalation follows a similar structure but uses different doses, starting at 2.5 mg and increasing in 2.5 mg increments every four or more weeks, up to a maximum maintenance dose of 15 mg. The 2.5 mg starting dose is for initiation only and is not an approved maintenance dose. Your prescriber will move you up from there based on how you’re tolerating the medication.
What To Expect at Each Stage
During the starting dose phase, you probably won’t feel much difference in appetite yet. This dose is below the therapeutic threshold. You might notice mild nausea, especially after injections, but many people tolerate this phase well.
As you increase to mid-range doses, appetite suppression typically kicks in noticeably. This is often when people start reporting that they forget to eat, feel full quickly, or lose interest in foods they used to crave, though individual experiences vary. GI side effects can increase during dose jumps.
At higher doses, most people have adjusted and side effects often lessen. If you’ve been tolerating the medication well and your doctor is satisfied with your progress, this is typically where you’ll stay.
What if Side Effects Are Too Much?
You don’t have to push through unbearable nausea or vomiting. If a dose jump is causing significant side effects, it’s completely appropriate to stay at the previous dose longer before moving up. Many prescribers are flexible about this. The goal is to find the highest dose you can tolerate comfortably, not to race to the maximum.
Talk to your doctor or prescriber before adjusting your schedule on your own.
Injection Tips for the Early Weeks
Inject on the same day each week to keep your schedule consistent
Common injection sites: abdomen, thigh, or upper arm
Rotate injection sites to avoid irritation
Keep the medication refrigerated until use; let it reach room temperature before injecting for more comfort
What to Keep in Mind as You Start
Dose escalation is a process, not a sprint. The first month or two is really about building tolerance, not seeing dramatic results. Stay patient, communicate with your doctor, and know that the adjustment period is temporary for most people.
The FDA-approved GLP-1 receptor agonist medications discussed in this article are prescription medications for specific indications: semaglutide (Ozempic®) for type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes and cardiovascular disease; semaglutide (Wegovy®) for chronic weight management; tirzepatide (Mounjaro®) for type 2 diabetes; and tirzepatide (Zepbound®) for chronic weight management. This article is for educational and informational purposes only and does not constitute medical advice. Individual results may vary. Consult your healthcare provider to determine if GLP-1 therapy is appropriate for your individual health situation and to discuss potential risks, side effects, and contraindications.
Leave a Comment
Your email address will not be published. Required fields are marked *